Viewing Study NCT02101593


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-03-02 @ 10:04 PM
Study NCT ID: NCT02101593
Status: COMPLETED
Last Update Posted: 2016-03-04
First Post: 2014-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer
Sponsor: Polaris Group
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: POLARIS2013-005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators